The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Adelman Daniel C Md since year 2005.
The trader's CIK number is 1222037.
At the time of this reporting, Adelman Daniel C Md is the Chief Medical Officer of Aimmune Therapeutics, Inc. .
(stock ticker symbol AIMT).
See this page for all insider trading activities at Aimmune Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-16||AIMT||Aimmune Therapeutics, Inc.||Sale||9,933||40.00||397,320|
|2018-01-12||AIMT||Aimmune Therapeutics, Inc.||Option Ex||26,784||11.45||306,676|
|2018-01-12||AIMT||Aimmune Therapeutics, Inc.||Sale||26,784||40.00||1,071,360|
|2018-01-16||AIMT||Aimmune Therapeutics, Inc.||Option Ex||9,933||11.45||113,732|
|2017-12-27||AIMT||Aimmune Therapeutics, Inc.||Sale||3,283||40.00||131,320|
|2017-12-27||AIMT||Aimmune Therapeutics, Inc.||Option Ex||3,283||11.45||37,590|
|2017-10-23||AIMT||Aimmune Therapeutics, Inc.||Sale||10,000||34.33||343,260|
|2017-10-23||AIMT||Aimmune Therapeutics, Inc.||Option Ex||10,000||11.45||114,500|
|2017-09-25||AIMT||Aimmune Therapeutics, Inc.||Option Ex||10,000||11.45||114,500|
|2017-09-25||AIMT||Aimmune Therapeutics, Inc.||Sale||10,000||25.00||250,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Adelman Daniel C Md (Chief Medical Officer of Aimmune Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.